Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Kidney Neoplasms 3Carcinoma, Renal Cell 1

Interventions

aldesleukin 43Sunitinib 42Cyclophosphamide 30Nivolumab 29pembrolizumab 27Everolimus 27Interferon-alpha 25Bevacizumab 23Sorafenib 22Interleukin-2 20fludarabine phosphate 19Radiotherapy 18Ipilimumab 18Filgrastim 18Axitinib 18Gene Expression Profiling 16Peripheral Blood Stem Cell Transplantation 15Gemcitabine 15cabozantinib 14Radiosurgery 13fludarabine 11Doxorubicin 11Carboplatin 11Blood Specimen Collection 11temsirolimus 10atezolizumab 9Immunohistochemistry 9Etoposide 9Chemotherapy, Adjuvant 9sargramostim 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Kidney Neoplasms × perflutren × Genitourinary × Clear all
NCT04021238 2023-11-13

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
25 enrolled 28 charts
Genitourinary

Kidney Neoplasms

NCT01751529 2017-03-17

Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
48 enrolled
Genitourinary

Kidney Neoplasms

NCT01894607 2016-04-14

Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy

M.D. Anderson Cancer Center

Phase NA Completed
11 enrolled 4 charts
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡